Our hematology, oncology, and blood and marrow transplant teams treat patients with all forms of cancer and blood disorders. Our specialists participate in collaborative research across the country and around the world to bring innovative treatments to our patients.| www.nationwidechildrens.org
An innovative method that uses a zebrafish model to rapidly study novel fusion-oncogenes in vivo has been developed by investigators at Nationwide Children’s Hospital.| Pediatrics Nationwide
Researchers published the first comprehensive, 3D analysis of the complete rhabdomyosarcoma genome.| Pediatrics Nationwide
Synergy is an important part of scientific endeavors, and people, teams and organizations who can harness the energy of ideas and passion for the work can leverage it to move their fields forward.| Pediatrics Nationwide
A new cellular therapy approach could improve outcomes and ease the treatment burden for patients and families.| Pediatrics Nationwide
How a new approach to correcting heterozygous mutations and other novel techniques for gene editing are transforming the potential to combat disease| Pediatrics Nationwide
Investigators from Nationwide Children’s Hospital created fratricide-resistant and metabolically-enhanced chimeric antigen receptor (CAR) natural killer (NK) and T cells that have cytotoxic effects on many hematologic tumors.| Pediatrics Nationwide
